Harry Mittelman, MD
Facial Plastic Surgery · Los Altos
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Mittelman’s office at (626) 814-9604 to ask if they take your plan before you enroll.
California Medical Board record
Licence C30674 · Current
Licensed to practise in California · since 1968 · expires 2029-02-28 · University of Kansas School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$601
Pharmacies billed $601 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 31% of their Part D prescriptions (18 of 59) in 2024. A higher opioid share than 9 in 10 peers; the typical otolaryngology clinician is at 4%.
53 generic and fewer than 11 brand-name prescriptions · $601 in drug cost · 24 antibiotic prescriptions to 24 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cephalexin | 23 | $276 | $12 |
| Hydrocodone-Acetaminophen | 17 | $108 | $6 |
Year by year
| 2024 | 59 | 26 | 31% (18) | None | $601 |
| 2023 | 60 | 23 | 28% (17) | None | $670 |
| 2022 | 51 | 19 | 22% (11) | None | $1,382 |
| 2021 | 28 | 11 | None | 0% | $319 |
| 2020 | 36 | None | None | None | $558 |
| 2019 | 20 | None | 0% (0) | None | $367 |
| 2018 | 25 | None | 0% (0) | None | $1,413 |
| 2017 | 42 | 12 | None | None | $563 |
| 2016 | 58 | 16 | None | None | $3,642 |
| 2015 | 86 | 20 | 17% (15) | None | $2,749 |
| 2014 | 83 | 21 | 17% (14) | 13% | $3,077 |
| 2013 | 78 | 18 | 17% (13) | 17% | $2,248 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Cephalexin | 21 | $285 | $14 |
| Hydrocodone-Acetaminophen | 16 | $91 | $6 |
2022: 1 drug
| Cephalexin | 13 | $76 | $6 |
2016: 1 drug
| Cephalexin | 12 | $84 | $7 |
2015: 4 drugs
| Valacyclovir | 16 | $552 | $34 |
| Minocycline | 11 | $111 | $10 |
| Cephalexin | 15 | $93 | $6 |
| Hydrocodone-Acetaminophen | 14 | $83 | $6 |
2014: 3 drugs
| Valacyclovir | 11 | $536 | $49 |
| Cephalexin | 17 | $119 | $7 |
| Hydrocodone-Acetaminophen | 12 | $69 | $6 |
2013: 2 drugs
| Cephalexin | 14 | $96 | $7 |
| Meloxicam | 11 | $89 | $8 |
Money from drug and device companies
$128 in 2025
| 2025 | 1 | 1 | None | $128 |
| 2024 | 1 | 1 | None | $23 |
| 2023 | 1 | 1 | None | $28 |
| 2022 | 2 | 2 | None | $27 |
| 2021 | 1 | 1 | None | $17 |
| 2020 | 2 | 5 | None | $116 |
| 2019 | 1 | 5 | None | $168 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Botox | $128 | 1 payment
|
See the published payment
| Abbvie | Meals · 2025-04-25 | Botox | $128 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $23
| Abbvie | Botox | $23 | 1 payment
|
2023: $28
| Abbvie | None | $28 | 1 payment
|
2022: $27
| Galderma Laboratories L.P. | None | $14 | 1 payment
|
| Merz North America | Xeomin | $14 | 1 payment
|
2021: $17
| Galderma Laboratories L.P. | None | $17 | 1 payment
|
2020: $116
| Galderma Laboratories L.P. | None | $99 | 4 payments
|
| Allergan | Botox Cosmetic | $17 | 1 payment
|
2019: $168
| Allergan | Botox Cosmetic | $168 | 5 payments
|
Professional record
- NPI
- 1467560466
- Licence
- CA C30674California C30674: Current · expires 2029-02-28
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207YS0123X (207YS0123X)
- Mailing address
- 795 Altos Oaks Dr, Los Altos, CA, 94024
- NPI first listed
- 2006-08-29
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.